QR kód

Practical Guidance on the Clinical Management of Ocular Adverse Events Associated with Belantamab Mafodotin for Patients with Relapsed/Refractory Multiple Myeloma: Latin American Expert Panel Recommendations

Abstract Multiple myeloma is a significant cause of mortality worldwide, and although changes in the treatment landscape have improved outcomes overall, many patients become refractory to standard therapies. In Latin America, outcomes are especially poor, further compounded by access and equality ba...

Celý popis

Uloženo v:
Hlavní autoři: Vânia Hungria, Virginia Abello Polo, Ariel Corzo, Edvan Q. Crusoe, Michel E. Farah, Natália A. Iutaka, Gracia A. Martinez, Aline G. Ramírez Alvarado, Simón Romano-Bucay, Patricio G. Schlottmann, Cristian M. Seehaus, Jorge C. Torres Flores, Angelo Maiolino
Médium: Artigo
Jazyk:Inglês
Vydáno: Adis, Springer Healthcare 2025-07-01
Edice:Oncology and Therapy
Témata:
Belantamab mafodotin
Clinical management
Latin America
Multiple myeloma
Ocular adverse events
On-line přístup:https://doi.org/10.1007/s40487-025-00354-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky